Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-238-7 | CAS number: 55-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1987 / 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- The incidence of IgE and IgG antibodies to chlorhexidine
- Author:
- Layton GT, Stanworth DR & Amos HE
- Year:
- 1 989
- Bibliographic source:
- Clin Experimen Allergy 19, 307–314
- Reference Type:
- publication
- Title:
- The specificity of murine polyclonal and monoclonal antibodies to the haptenic drug chlorhexidine induced by chlorine-generated chlorhexidine-protein conjugates
- Author:
- Layton GT, Stanworth DR & Amos E
- Year:
- 1 987
- Bibliographic source:
- Clin exp Immunol 69, 157-165
Materials and methods
- Study type:
- other: immunological study
Test material
- Reference substance name:
- Chlorhexidine
- EC Number:
- 200-238-7
- EC Name:
- Chlorhexidine
- Cas Number:
- 55-56-1
- Molecular formula:
- C22H30Cl2N10
- IUPAC Name:
- N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
Constituent 1
Results and discussion
Applicant's summary and conclusion
- Executive summary:
The authors investigated the incidence of IgE and IgG antibodies to chlorhexidine by radio-allergosorbent technique (RAST) for IgE and enzyme linked immunosorbent assay (ELISA) for IgG and IgE using semi-chlorhexidine human serum albumin conjugates for both assays. Serum samples from Japanese patients having suffered from anaphylactic reactions and chlorhexidine exposed hospital staff from Japan and Great Britain as well as non-exposed patients were tested.
IgE antibodies to chlorhexidine were only detected in Japanese individuals with anaphylactic-type reactions to chlorhexidine, not in the other Japanese groups and not in the British hospital staff. In contrast, IgG antibodies to chlorhexidine were detected in sera of Japanese nurses and British hospital staff with regular contact to chlorhexidine.
The authors concluded that there was no evidence to suggest that the presence of serum IgG antibodies has any clinical relevance whatsoever and that further studies are needed for the determination of fine specificity of human IgE and IgG antibodies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
